Compare VNDA & LXFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VNDA | LXFR |
|---|---|---|
| Founded | 2002 | 1898 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 441.5M | 376.0M |
| IPO Year | 2006 | 2012 |
| Metric | VNDA | LXFR |
|---|---|---|
| Price | $8.10 | $15.77 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $13.63 | N/A |
| AVG Volume (30 Days) | ★ 2.8M | 96.1K |
| Earning Date | 02-12-2026 | 02-24-2026 |
| Dividend Yield | N/A | ★ 3.40% |
| EPS Growth | N/A | ★ 55.43 |
| EPS | N/A | ★ 0.53 |
| Revenue | $212,074,000.00 | ★ $397,300,000.00 |
| Revenue This Year | $12.01 | $0.62 |
| Revenue Next Year | $24.28 | N/A |
| P/E Ratio | ★ N/A | $28.96 |
| Revenue Growth | ★ 11.12 | 3.36 |
| 52 Week Low | $3.81 | $9.41 |
| 52 Week High | $9.60 | $15.50 |
| Indicator | VNDA | LXFR |
|---|---|---|
| Relative Strength Index (RSI) | 61.30 | 75.10 |
| Support Level | $7.14 | $14.70 |
| Resistance Level | $7.82 | $15.50 |
| Average True Range (ATR) | 0.44 | 0.44 |
| MACD | -0.05 | 0.11 |
| Stochastic Oscillator | 62.09 | 90.38 |
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
Luxfer Holdings PLC is a manufacturer industrial company innovating niche applications in materials engineering. It focuses on value creation by using its broad array of technical know-how and proprietary technologies to help create a safe, clean, and energy-efficient world. Luxfer's high-performance materials, components, and high-pressure gas containment devices are used in defense, first response and healthcare, transportation, and general industrial applications. It focuses on product lines related to magnesium alloys, zirconium chemicals, and carbon composites. Its segments are Elektron, Gas Cylinders, and Graphic Arts. It generates the majority of its revenue from Elektron and as well as Gas Cylinders.